Transformation in recurrent ovarian granulosa cell tumors: ki67 (mib-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior

Human Pathology

Volumn 27, Issue 3, 1996, Pages 274-281

  Costa, Michael J ^a   Walls, Judy ^b   Ames, Peter ^b   Roth, Lawrence M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

ovary; prognosis; proliferation; sex cord stromal tumors

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN P53; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CELL PROLIFERATION; CELL TRANSFORMATION; CHILD; GENE EXPRESSION; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS RATE; OVARY; PROGNOSIS; SEX CORD TUMOR;

EID: 0029969426     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90069-6     Document Type: Article

References (35)

1. Fox H: Sex cord-stromal tumors of the ovary. J Pathol 145:127-148, 1985
2. Young RH, Scully RE: Ovarian sex cord-stromal tumors: Recent progress. Int J Gynecol Pathol 1:101-123, 1982
3. Young RH, Scully RE: Ovarian sex cord-stromal tumors: Problems in differential diagnosis. Pathol Annu 23:237-296, 1988
4. Fox H, Agrawal K, Langley FA: A clinicopathologic study of 92 cases of granulosa cell tumor or the ovary with special reference to the factors influencing prognosis. Cancer 35:231-241, 1975
5. Stenwig JT, Hazekamp JT, Beecham JB: Granulosa cell tumors of the ovary: A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 7:136-152, 1979
6. Bjorkholm E, Silfversward C: Prognostic factors in granulosa-cell tumors. Gynecol Oncol 11:261-274, 1981
7. Zaloudek C, Norris H: Granulosa tumors of the ovary in children: A clinical and pathologic study of 32 cases. Am J Surg Pathol 6:513-522, 1982
8. Evans AT, Gaffey TA, Malkasian GD, et al: Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 55:231-238, 1980
9. Dempster J, Giersson, Duncan ID: Survival after granulosa and theca cell tumours. Scott Med J 32:38-39, 1987
10. Malmstrom H, Hogberg T, Risberg B, et al: Granulosa cell tumors of the ovary: Prognostic factors and outcome. Gynecol Oncol 52:50-55, 1994
11. Haba R, Miki H, Kobayashi S, et al: Combined analysis of flow cytometry and morphometry of ovarian granulosa cell tumor. Cancer 72:3258-3262, 1993
12. Klemi PJ, Joensuu H, Salmi T: Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary. Cancer 65:1189-1193, 1990
13. Jacoby AF, Young RH, Colvin RB, et al: DNA content in juvenile granulosa cell tumors of the ovary: A study of early- and advanced-stage disease. Gynecol Oncol 46:97-103, 1992
14. Bell DA: Flow cytometry of ovarian neoplasms. Curr Top Pathol 85:337-356, 1992
15. Swanson SA, Norris HJ, Kelsten ML, et al: DNA content of juvenile granulosa tumors determined by flow cytometry. Int J Gynecol Pathol 9:101-109, 1990
16. Chadha S, Cornelisse CJ, Schaberg A: Flow cytometric DNA ploidy analysis of ovarian granulosa cell tumors. Gynecol Oncol 36:240-245, 1990
17. Kwang-Sun S, Silverberg SG, Rhame JG, et al: Granulosa cell tumor of the ovary: Histopathologic and flow cytometry analysis with clinical correlation. Arch Pathol Lab Med 114:496-501, 1990
18. Gerdes J, Li L, Schlueter C, et al: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867-873, 1991
19. Cattoretti G, Becker MH, Key G, et al: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363, 1992
20. Barbareschi M, Girlando S, Mauri FM, et al: Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas. Am J Clin Pathol 102:171-175, 1994
21. DeLellis RA: Does the evaluation of proliferative activity predict malignancy or prognosis in endocrine tumors. HUM PATHOL 26:131-134, 1995
22. Vogelstein B, Kinzler KW: p53 Function dysfunction. Cell 70:523-526, 1992
23. Marx J: How p53 suppresses cell growth. Science 262:1644-1645, 1993
24. Harris CC: p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 262:1980-1981, 1993
25. Jensen RA, Page DL: p53: The promising story continues to unfold. HUM PATHOL 24:455-456, 1993
26. Klemi PJ, Takahashi S, Joensuu H, et al: Immunohistochemical detection of p53 protein in borderline and malignant serous ovarian tumors. Int J Gynecol Pathol 13:228-233, 1994
27. Bosari S, Viale G, Radaelli U, et al: p53 Accumulation in ovarian carcinomas and its prognostic implications. HUM PATHOL 24:1175-1179, 1993
28. Teneriello MG, Ebina M, Linnoila RI, et al: p53 and Ki-ras Gene mutations in epithelial ovarian neoplasms. Cancer Res 53:3103-3108, 1993
29. Kohler MF, Kerns BJ, Humphrey PA, et al: Mutation and overexpression of p53 in early-stage epithelial ovarian cancer. Obstet Gynecol 81:643-650, 1993
30. Taylor CR, Shi SR, Chaiwun B, et al: Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin section: Androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen and Ki67 antigen revealed by antigen retrieval techniques. HUM PATHOL 25:263-270, 1994
31. Costa MJ, DeRose PB, Roth LM, et al: Immunohistochemical phenotype of ovarian granulosa cell tumors: Absence of epithelial membrane antigen has diagnostic value. HUM PATHOL 25:60-66, 1994
32. Duncan RC, Knapp RG, Miller MC: Introductory Biostatistics for the Health Sciences. New York, NY, Wiley, 1977
33. Hitchcock CL, Norris HJ, Khalifa MA, et al: Flow cytometric analysis of granulosa tumors. Cancer 64:2127-2132, 1989
34. Kounelis S, Papadaki H, Kanbour-Shakir A, et al: p53 Point mutational damage predicts tumor recurrence in ovarian adenocarcinoma. Mod Pathol 8:92A, 1995
35. Katoh R, Bray CE, Suzuki K, et al: Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal MIB-1. HUM PATHOL 26:139-146, 1995